Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $842M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Alcon AG ALC:SW USD 20M 0
Almirall ALM:SM EUR 21.78M 0
Artemis Alpha ATS:LN GBP 373K 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
Eli Lilly LLY:US USD 593.5M 600K
Galapagos GLPG:NA EUR 293.94M 333K
Genmab GEN:DC DKK 66M 0
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Hikma Pharmaceutical HIK:LN USD 40M 1000K
J&J JNJ:US USD 3.12B 0
Lonza Group LONN:SW CHF 74M 0
Merck MRK:GR EUR 565M 397M
Novartis NOVN:VX USD 842M 48M
Novartis NVS:US USD 842M 48M
Orion ORNBV:FH EUR 92.2M 0
Recordati REC:IM EUR 26.14M 0
Roche Holding ROG:VX CHF 107M 0